Q4 2024 Earnings Call Transcript March 11, 2025 Voyager Therapeutics, Inc. misses on earnings expectations. Reported EPS is $ ...

Wells Fargo analyst Yanan Zhu lowered the firm’s price target on Voyager Therapeutics (VYGR) to $10 from $12 and keeps an Overweight rating on ...

In a report released yesterday, Yanan Zhu from Wells Fargo maintained a Buy rating on Voyager Therapeutics (VYGR – Research Report), with a ...

The twin spacecraft launched in 1977 and are currently in interstellar space, or the space between stars. Voyager 1 ...

Science correspondent Allan Blackman joins Kathryn to talk about a new part of the immune system that's been discovered and how it could be a goldmine of potential antibiotics. NASA has switched off ...

Voyager Therapeutics (VYGR) delivered earnings and revenue surprises of -68.57% and 68.81%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the ...

Voyager Therapeutics Inc. (VYGR) on Tuesday reported a loss of $34.5 million in its fourth quarter. On a per-share basis, the Lexington, Massachusetts-based company said it had a loss of 59 cents. The ...

Pomerantz LLP is investigating claims on behalf of investors of Celanese Corporation ("Celanese" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or ...